Unichem Laboratories Ltd

NSE: UNICHEMLAB · BSE: 506690 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹547.15
Market cap: ₹3,852 Cr
Revenue (annual): ₹2,202 Cr
Net profit (annual): ₹252.8 Cr
P/E (TTM): 12.6×Sector 47.4×
Promoter holding: 70.22%+0.00% QoQ
FII holding: 0.90%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Price Movement Clarification 3 Other Announcement 3 Legal & Regulatory 3 Financial Results 3 Annual General Meeting 3 Business Update 2 Board Meeting Date 2 Employee Stock Options 1 Credit Rating 1 Board Meeting Outcome 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

12 Apr 2026 18:54 IST BSE

Adverse Business Impact

Unichem Laboratories Adverse Business Impact

Unichem Laboratories Ltd's US subsidiary has voluntarily recalled Buspirone Hydrochloride Tablets (5 mg) due to an out-of-specification assay result identified during stability testing. No adverse events have been reported. The company maintains its focus on patient safety and quality standards throughout its supply chain.

Read the filing ↗